Gw&K Investment Management, LLC P Lx Pharma Inc. Transaction History

Gw&K Investment Management, LLC

  • $11.3 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$1.9 - $4.18 $6,175 - $13,584
-3,250 Reduced 0.76%
424,921 $1.03 Million
Q1 2022

May 09, 2022
SELL
$3.54 - $8.3 $16,638 - $39,010
-4,700 Reduced 1.09%
428,171 $1.73 Million
Q4 2021

Feb 11, 2022
SELL
$7.69 - $19.66 $182,445 - $466,433
-23,725 Reduced 5.2%
432,871 $3.47 Million
Q3 2021

Nov 10, 2021
BUY
$12.22 - $21.28 $32,688 - $56,924
2,675 Added 0.59%
456,596 $8.81 Million
Q1 2021

May 11, 2021
BUY
$5.24 - $10.14 $2.38 Million - $4.6 Million
453,921 New
453,921 $4.1 Million

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email